Testing effectiveness (Phase 2)Looking for participantsNCT06262438
What this trial is testing
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
Who this might be right for
Acute Myeloid Leukemia in Children
Princess Maxima Center for Pediatric Oncology 60